Abstract
Answer E. Ramipril
A Renin–Angiotensin System (RAS) blocker (angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB)) remains the preferred first-line therapy for individuals with chronic kidney disease (CKD), hypertension and urine albumin/creatinine ratio (ACR) >30 mg/mmol.
InnovAiT article: Stepwise management of chronic kidney disease in primary care. DOI: 10.1177/17557380261435934.
DOI: 10.1177/17557380261446499r